InZS AssociatesbyZS·Sep 9MFN and the new geography of pricing riskWhy pricing connectivity may reshape launch sequencing and the role of some emerging markets
Darwin Gosal·Aug 8Who Pays for the Next Cure?Drug prices, national sovereignty, and the strange politics of pharmaceutical “free-riding”
Students for Patient Advocacy Nationwide·Jun 14Trump Tries Most Favored Nation Drug Pricing Again — Will it Work?A while ago, President Trump declared that “My next truth will be one of the most important and impactful I have ever issued.” A day later…
John Matthew·Oct 6, 2025Reflection-Trump’s New Enemies: Billionaires, Big Pharma, & Bibi? The David McWilliams Podcasthttps://shows.acast.com/the-david-mcwilliams-podcast/episodes/trumps-new-enemies-billionaires-big-pharma-bibi
InInsiderFinance WirebyFábio Ferreira·Oct 1, 2025TrumpRx: America’s New Direct Drug Portal — Affordable or Overhyped?In late September 2025, former President Donald Trump announced a bold initiative: TrumpRx, a government-backed website intended to let…
Ronald Muhizi, MD, Mpharm·Sep 18, 2025Why Big Pharma is Pausing UK InvestmentIn recent weeks, headlines have been dominated by news that some of the world’s largest pharmaceutical companies are pausing or pulling…A response icon1A response icon1
Andrew Zuo·Jul 2, 2025Trump Wants To Export The US’s Drug PricesTrump has signed Executive Order 14,297 titled ‘Delivering Most-Favored-Nation Prescription Drug Pricing To American Patients’ This forces…A response icon2A response icon2
S. C. Harist·May 16, 2025Rx: A New Patent DealHow a Voluntary Pharma Patent Scheme Can Expand Access Without Sacrificing ProfitA response icon1A response icon1
InBeingWellbyChristopher Nial·May 15, 2025Analysis: Executive Order “Delivering Most-Favored-Nation Prescription Drug Pricing to American…The implications differ substantially across the three primary stakeholders: pharmaceutical companies, payers and patients.
InBeingWellbyChristopher Nial·May 12, 2025Trump’s Drug Price Gambit: Cheaper for America, But Who Pays the Price?On May 12, 2025, Donald Trump signed an executive order to cut U.S. prescription drug prices by linking U.S. drug prices to other…A response icon1A response icon1
